Filing Details
- Accession Number:
- 0001209191-10-058374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-03 12:00:00
- Reporting Period:
- 2010-12-01
- Filing Date:
- 2010-12-03
- Accepted Time:
- 2010-12-03 16:52:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1442675 | Daniel Scott Cormack | 400-1001 W. Broadway Vancouver A1 V6H 4B1 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-01 | 5,000 | $3.89 | 18,067 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-01 | 5,000 | $16.02 | 13,067 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-03 | 5,000 | $3.89 | 18,067 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-03 | 5,000 | $0.00 | 13,067 | No | 4 | G | Direct | |
| Common Stock | Acquisiton | 2010-12-03 | 5,000 | $0.00 | 35,680 | No | 4 | G | Indirect | By Trycor Investment Trust No.1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Indirect | By Trycor Investment Trust No.1 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common | Stock options | Disposition | 2010-12-01 | 3,709 | $0.00 | 3,709 | $3.89 |
| Common | Stock Options | Disposition | 2010-12-01 | 1,291 | $0.00 | 1,291 | $3.89 |
| Common | stock Options | Disposition | 2010-12-03 | 5,000 | $0.00 | 5,000 | $3.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-12-16 | 2010-12-16 | No | 4 | M | Direct |
| 20,268 | 2007-01-14 | 2011-01-14 | No | 4 | M | Direct |
| 15,268 | 2007-01-14 | 2011-01-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,092 | Indirect | Spouse |
Footnotes
- Scott D. Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1
- These shares were exercised and sold under the 10b5 Sales Plan
Billionaire Hedge Funds
